Pulmonary fibrosis is the result of dysregulated repair after tissue injury. Idiopathic pulmonary fibrosis (IPF) remains a devastating, progressive disease with no known cure and currently no treatment that effectively alters the disease course. While the inciting etiology of IPF is still not clear, increasing evidence suggests that hot immune responses contribute to the persistent fibrotic reaction and represents a potential new area for therapeutic intervention. The Wnt/?-catenin pathway has been well described as a determiner of cell fate; recent studies showed that canonical Wnt/?-catenin signaling plays a pivotal role in myeloid cell activation in the gastrointestinal tract and skin. Studies from our la demonstrate that global loss of the Wnt co-receptor Lrp5 is protective against bleomycin-induced pulmonary fibrosis and gene expression analysis of Lrp5-null lungs indicates that the pathways most perturbed are related to immune response and extracellular matrix turnover. Consistent with these microarray data, flow cytometry analysis reveals that Wnt/?-catenin signaling is highly activated in lung myeloid cells and that ?-catenin/Lrp5 signaling alters macrophage differentiation/activation. Collectively, our data strongly suggest that sustained Wnt signaling is a driver of lung fibrosis and that key Wnt-activated cell types include immune cells. We hypothesize that ?-catenin signaling promotes the differentiation of monocytes into recruited alveolar macrophages, which ultimately impacts the innate immune response and aggravates tissue repair. We predict that inhibition of ?-catenin signaling in monocyte-derived macrophages promotes the resolution of pulmonary fibrosis (Aim 1). We propose that canonical Wnt/?-catenin is required for differentiation of monocyte-derived alveolar macrophages after lung injury (Aim 2). Thus we anticipate that Wnt/?-catenin dysregulation in a subpopulation of PBMCs can be used to predict disease outcome in patients with IPF (Aim 3). Recruitment of macrophages to the lungs after injury is critical not only for host defense but also tissue repair. This project focuses on a novel and important area of investigation linking a key developmental pathway to the innate immune response in lung repair. The findings from this project will be the first to establish the role of the Wnt/?-catenin pathway in macrophage differentiation/activation in the innate immune response for resolution of lung injury.

Public Health Relevance

The studies from this project will be the first to establish the link between the Wnt/?-catenin pathway and macrophage differentiation/innate immune response in lung repair after injury. This project will also demonstrate that a subpopulation of peripheral blood mononuclear cells expressing a Wnt pathway dysregulation/?-catenin gene signature can be used to predict disease outcome in patients with IPF. These findings will further our current understanding regarding how host immune responses contribute to the persistent fibrotic reaction and represents a potential new area for therapeutic intervention for IPF.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
High Priority, Short Term Project Award (R56)
Project #
1R56HL127245-01A1
Application #
9325627
Study Section
Lung Injury, Repair, and Remodeling Study Section (LIRR)
Program Officer
Harabin, Andrea L
Project Start
2016-09-15
Project End
2017-08-31
Budget Start
2016-09-15
Budget End
2017-08-31
Support Year
1
Fiscal Year
2016
Total Cost
$611,380
Indirect Cost
$220,722
Name
Northwestern University at Chicago
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
005436803
City
Chicago
State
IL
Country
United States
Zip Code
60611
Sennello, Joseph A; Misharin, Alexander V; Flozak, Annette S et al. (2017) Lrp5/?-Catenin Signaling Controls Lung Macrophage Differentiation and Inhibits Resolution of Fibrosis. Am J Respir Cell Mol Biol 56:191-201
Misharin, Alexander V; Morales-Nebreda, Luisa; Reyfman, Paul A et al. (2017) Monocyte-derived alveolar macrophages drive lung fibrosis and persist in the lung over the life span. J Exp Med 214:2387-2404